- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01529996
Pulsed Dye Laser (PDL) vs. Microsecond 1064-nm Nd:YAG Laser for Treatment of Diffuse Facial Redness
November 30, 2021 updated by: Murad Alam, Northwestern University
Comparison of the Efficacy Between Pulsed Dye Laser (PDL) and the Microsecond 1064-nm Nd:YAG Laser for Treatment of Diffuse Facial Redness: A Pilot, Prospective Randomized Trial.
The primary objective of this study is to compare the efficacy of PDL and the 1064-nm Nd:YAG laser in the treatment of facial redness.
Study Overview
Study Type
Interventional
Enrollment (Actual)
16
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Northwestern University Feinberg School of Medicine, Department of Dermatology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy patients 18-55 years of age with erythematotelangiectatic rosacea (as verified by the the PI).
- Subjects who are willing to provide informed consent for participation in the study.
Exclusion Criteria:
- Pregnant or lactating individuals
- Subjects who are unable to understand the protocol or to give informed consent.
- Subjects who have a known history of photosensitive conditions (e.g. Systemic lupus, polymorphous light eruption)
- Subjects who have facial telangiectasia of diameter greater than 2 mm.
- Subject who have significant (as determined by the PI) acute inflammatory papules, pustules, and vesicle involving the central face.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: YAG laser
|
This study involves treatments with two types of lasers, Pulsed dye lasers (PDL) and the 1064 nm Nd: YAG.
Both lasers are FDA approved to treat vascularities in the skin.
|
Active Comparator: Pulse Dye Laer
|
This study involves treatments with two types of lasers, Pulsed dye lasers (PDL) and the 1064 nm Nd: YAG.
Both lasers are FDA approved to treat vascularities in the skin.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rating on global improvement scale
Time Frame: four months
|
Non-treating dermatologists will rate each side of the face using a global improvement scale to evaluate the effectiveness of the two treatments.
|
four months
|
Spectrophotometer measurement
Time Frame: four months
|
Spectrophotometer measurement as the percent resolution on each follow up visit compared to baseline visit
|
four months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient satisfaction
Time Frame: four months
|
Patients will record satisfaction on the questionnaires provided
|
four months
|
Recorded discomfort
Time Frame: four months
|
Subjects will record discomfort using a 10-point scale
|
four months
|
Adverse events
Time Frame: four months
|
Any adverse events will be recorded
|
four months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2012
Primary Completion (Actual)
August 1, 2012
Study Completion (Actual)
August 1, 2012
Study Registration Dates
First Submitted
February 7, 2012
First Submitted That Met QC Criteria
February 8, 2012
First Posted (Estimate)
February 9, 2012
Study Record Updates
Last Update Posted (Actual)
December 2, 2021
Last Update Submitted That Met QC Criteria
November 30, 2021
Last Verified
November 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU55489
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rosacea
-
Amorepacific CorporationCompletedPapulopustular Rosacea | Erythematotelangiectatic RosaceaKorea, Republic of
-
Actavis Inc.CompletedModerate to Severe Papulopustular RosaceaUnited States
-
University of California, DavisCompletedRosacea | Ocular Rosacea | Cutaneous RosaceaUnited States
-
bioRASI, LLCCompletedPapulopustular Rosacea | Erythematotelangiectatic RosaceaUnited States
-
Bionou Research, S.L.RecruitingRosacea | Rosacea, Papulopustular | Rosacea Papular TypeSpain
-
Galderma R&DCompleted
-
Cutera Inc.CompletedPapulopustular Rosacea | Erythematotelangiectatic RosaceaUnited States
-
Eye Associates of Central TexasWithdrawn
-
Dermata TherapeuticsActive, not recruiting
-
AiViva BioPharma, Inc.Withdrawn
Clinical Trials on Pulse Dye Laser/YAG laser
-
The Metis FoundationUnited States Army Institute of Surgical ResearchCompletedHypertrophic ScarUnited States
-
Massachusetts General HospitalShriners Hospitals for ChildrenUnknownBurn ScarsUnited States
-
Henry Ford Health SystemAmerican Academy of Cosmetic SurgeryCompletedPost Surgical ScarsUnited States
-
Cairo UniversityCompleted
-
Cynosure, Inc.Completed
-
University of California, DavisWithdrawn
-
Northwestern UniversityEnrolling by invitation
-
Aljazeera HospitalNational Research Centre, EgyptUnknown
-
Montefiore Medical CenterNot yet recruitingHidradenitis Suppurativa | ScarringUnited States